About ATCC
ATCC is a company based in Manassas (United States) founded in 1925. ATCC operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Latest Funding Round$133.81K (USD), Grant
Jul 2009
- Investors
Funding Insights of ATCC
- Total Rounds 2
- Last Round Grant — $133,809
- First Round $133,809
(Jul 2008)
- Investors Count 1
All 2 funding rounds of ATCC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in ATCC
ATCC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for ATCC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ATCC
52 people are tracked at ATCC (21 in leadership, 31 in team).
| Name | Role | Group |
|---|---|---|
Patrick J. Laverty | Chief Quality, Regulatory & Safety Officer | Leadership |
Teri Sellars | VP, Human Resources & Chief People Officer | Leadership |
Mindy Goldsborough | Chief Science & Technology Officer | Leadership |
Ruth Cheng | SVP & General Manager, Research & Industrial Solutions | Leadership |
Raymond H. Cypess | Chairman, CEO | Leadership |
Chad Madaloni | Director Of Quality | Leadership |
Scott Boller | Chief Financial Officer | Leadership |
Linda Johnson | VP, Licensing & Intellectual Property Management | Leadership |
Angela Biehl | Director Talent Acquisition | Leadership |
Eldar Imanverdi | Senior Director, Business Development, ATCC Federal Solutions | Leadership |
Rebecca Bradford | VP, Government Programs | Leadership |
Heather Couch | Director, Government Programs | Leadership |
Rupali Singh | Vice President Of Commercial Operations | Leadership |
Mabs Imala | Director Of Financial Planning And Analysis | Leadership |
Viqar Aslam | Senior Director Corporate Development, Strategic Partnerships | Leadership |
Sujatha Rashid | Director, Government Programs | Leadership |
Nilay Chakraborty | Director Of Cryobiology, Bionexus Foundation Principal Scientist | Leadership |
Antonia H. | Director | Leadership |
Zaneta Purvis | Director Of Procurement | Leadership |
Debra Lopez | Senior Director Supply Chain | Leadership |
32 more people are available in the full profile.
Complete people profiles for ATCC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ATCC
3 dated milestones of ATCC across 84 years, from founding to its latest funding, stage changes and deals.
- Founded ATCC is founded.
- Funding First funding round of $134K.
- Funding Latest funding round, Grant, of $134K.
Competitors of ATCC
ATCC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of ATCC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ATCC
The website of ATCC (atcc.org) receives about 408.3K visits a month and ranks #141,426 among all websites worldwide, #9,114 in Biology.
- Monthly visits408.3K
▲ 19.2% vs previous month
- Unique visitors156.8K
per month
- Global rank#141,426
among all websites
- Category rank#9,114
Science and Education · Biology
- Bounce rate49%
- Pages per visit2.3
- Average visit1 min 52 sec
- DevicesDesktop 59% · Mobile 41%
Websites whose visitors overlap most with ATCC. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
lgcstandards-atcc.org | lgcstandards-atcc.org | 100% | – | – | – |
| sciencellonline.com | 98% | – | #800,849 | View details | |
| dsmz.de | 98% | 555.7K | #117,555 | View details | |
| abcam.com | 97% | 602.8K | #91,958 | View details | |
| rndsystems.com | 96% | 349K | #159,292 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ATCC
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Atcc
Complete news archive for ATCC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ATCC
10 companies that operate in the same segment as ATCC (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ATCC
ATCC was founded in 1925 and raised its 1st funding round 83 years after it was founded.
ATCC is headquartered in Manassas, United States. It is registered at Manassas, Virginia, United States.
ATCC was founded in 1925 in Manassas, United States, and operates in the biotechnology sector focused on cell biology. Human and animal cell lines, including primary, immortalized, and stem cells, are distributed alongside microbial derivatives, culture media, reagents, and molecular genomic tools. Manufacturing facilities are maintained with ISO certification to support global research and development needs.
ATCC's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
ATCC has 1 investor. Key investors include HHS.
ATCC operates through Biodominion, Inc..
The website of ATCC receives about 408 thousand visits a month and ranks #141,426 among all websites worldwide.